Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1990-10-01
1992-07-07
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Lymphokine
4351721, 4351723, 4352351, 4353201, 935 12, 935 32, A61K 39265, A61K 3576, C12N 700, C12N 701
Patent
active
051281295
ABSTRACT:
Infectious bovine rhinotracheitis virus (bovine herpesvirus type 1) mutants containing deletion and/or insertion mutations in a major viral glycoprotein gene, such that no antigenic polypeptides encoded by the viral gene are produced, vaccines for infectious bovine rhinotracheitis containing the same, methods for the production of the same and methods for use of the same. Animals vaccinated with these mutants do not develop antibodies to the viral glycoprotein and can be distinguished serologically from animals infected with infectious bovine rhinotracheitis virus field strains.
REFERENCES:
patent: 4810634 (1989-03-01), Post et al.
Van Drunen Littel-Van den Hurk et al. (1986) J. Virol 59(2), 401-410.
Zuckermann et al. (1990) J. Virol, 64(2), 802-812.
Robbins et al. (1986) J. Virol, 58(2), 339-347.
Robbins et al. (1986) J. Virol, 59(3), 635-645.
Kit Malon
Kit Saul
Otsuka Haruki
Baker R. Keith
Baylor College of Medicine
Novagene Inc.
Wax Robert A.
LandOfFree
Infectious bovine rhinotrachetis virus mutants, vaccines contain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Infectious bovine rhinotrachetis virus mutants, vaccines contain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Infectious bovine rhinotrachetis virus mutants, vaccines contain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1828393